MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivo

Thomas V. Guy, Alexandra M. Terry, Helen M. McGuire, Elena Shklovskaya, Barbara Fazekas de St Groth*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
44 Downloads (Pure)

Fingerprint

Dive into the research topics of 'MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences